A powerful recent article by Peter Antevy, MD, FAEMS highlights a truth many clinicians already know: when it comes to prehospital blood transfusion, the medicine is far ahead of the money.
The article opens with the story of Angela Johnson, a highway worker who survived catastrophic injuries after being ejected from her truck because her local EMS agency carried whole blood. Paramedics made the decision to transfuse her at the scene, and her vital signs improved almost immediately. Without that early intervention, she was told she likely would not have survived. Today, Angela is alive to hold her grandchildren because whole blood was available when and where she needed it most.
Stories like Angela’s are not rare, but access to prehospital blood still is. Despite overwhelming clinical evidence and cost-effectiveness data showing that prehospital blood saves lives at a remarkably low cost, most EMS agencies cannot afford to carry it. Research presented at a national conference estimates the cost at just $164 per additional year of healthy life gained, making it one of the most cost-effective interventions in modern medicine.
So why isn’t it everywhere? As the article explains, the barrier isn’t science. It’s policy. Federal reimbursement models still classify EMS as a transportation service rather than a mobile healthcare system. That outdated framework means agencies are rarely reimbursed for lifesaving interventions like blood transfusion, even as hospitals would bill thousands for the same treatment.
The article also looks to the future, highlighting innovations such as spray-dried plasma that could make prehospital blood programs even more accessible, particularly for rural and underserved communities. With easier storage, longer shelf life, and fewer logistical barriers, these advancements could dramatically expand who benefits from early blood administration.
The conclusion is clear and urgent: the data is settled, the lives at stake are real, and the solution is achievable. Updating how EMS care is funded would allow more agencies to provide evidence-based, lifesaving treatment before patients ever reach the hospital.
Read the full article, including Angela’s story and the data behind the argument, here.